Integrated BioPharma, Inc. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was USD 12.92 million compared to USD 12.33 million a year ago. Net loss was USD 0.059 million compared to USD 0.035 million a year ago.